Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.3%

6 terminated/withdrawn out of 181 trials

Success Rate

91.8%

+5.2% vs industry average

Late-Stage Pipeline

29%

53 trials in Phase 3/4

Results Transparency

7%

5 of 67 completed trials have results

Key Signals

37 recruiting5 with results4 withdrawn

Enrollment Performance

Analytics

N/A
61(43.6%)
Phase 4
42(30.0%)
Phase 2
15(10.7%)
Phase 1
11(7.9%)
Phase 3
11(7.9%)
140Total
N/A(61)
Phase 4(42)
Phase 2(15)
Phase 1(11)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (181)

Showing 20 of 181 trials
NCT07852637Phase 4Not Yet Recruiting

Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism

Role: collaborator

NCT07238725Not ApplicableCompleted

The Efficacy of Aldehyde Dehydrogenase Enzyme in Essential Tremor Patients: A Single-Center Study

Role: collaborator

NCT05427786Phase 4Recruiting

A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease

Role: lead

NCT07572032Phase 4Recruiting

Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

Role: collaborator

NCT07631156Phase 4Recruiting

STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure

Role: collaborator

NCT07796217Phase 4Recruiting

Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy

Role: collaborator

NCT07792772Not ApplicableCompleted

Arrhythmia Detection With MEMO Patch Plus in Patients With Acute Heart Failure

Role: collaborator

NCT06474026Not ApplicableRecruiting

Bilateral Nucleus Accumbens Focused Ultrasound Neuromodulation for Stimulant Use Disorder

Role: lead

NCT06643572Not ApplicableCompleted

Comparing of Using Patient Imaging and Virtual Reality-based Simulation Prior to Lumbar Transforaminal Injections

Role: lead

NCT07280780Not Yet Recruiting

CGM-Based Glycemic Analysis After ESI

Role: lead

NCT04284943Not ApplicableRecruiting

Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery

Role: lead

NCT06786039Recruiting

Clinical Impact of Non-invasive Neurally Adjusted Ventilatory Assist in Very Preterm Infants

Role: lead

NCT06099366Phase 2Recruiting

Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

Role: collaborator

NCT06184009Phase 2Recruiting

Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia

Role: collaborator

NCT07726901Not ApplicableRecruiting

Empirical Anatomy-Based Ablation vs Emphasize Map-Guided Substrate Ablation in Persistent Atrial Fibrillation : (COMPASS-AF)

Role: collaborator

NCT07634666Recruiting

Prediction of Myocardial Injury After Non-Cardiac Surgery in Urologic Cancer Patients

Role: lead

NCT06929897Not ApplicableEnrolling By Invitation

PVI Alone vs PVI With Posterior Wall Isolation for Pulse-Field Ablation in Persistent AF

Role: collaborator

NCT06388720Phase 2Recruiting

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Role: collaborator

NCT07465549Not ApplicableRecruiting

CART BP Pro-Guided Blood Pressure Management for Uncontrolled Hypertension

Role: lead

NCT07329699Not ApplicableRecruiting

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

Role: collaborator